Home » Merck deflates on Wall Street, Covid pill effectiveness lower than expected

Merck deflates on Wall Street, Covid pill effectiveness lower than expected

by admin
  1. Home ››
  2. News >>
  3. World News ››


FACEBOOK
TWITTER
LINKEDIN

Merck and its partner Ridgeback Biotherapeutics announced that their Covid experimental pill reduced the risk of death and hospitalization in at-risk patients by 30%. This was a lower efficacy rate than that seen in a previous study which indicated a reduction of nearly 50%. On Wall Street, Merck shares lost 3.5%.

See also  56 selected tier companies released semi-annual reports, 12 companies' net profit increased by more than 50% year-on-year_Fujida

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy